Results 131 to 140 of about 53,618 (254)

Contraceptive Alignment: A Descriptive Study of Concordance between Preferred and Actual Contraceptive Method Use

Studies in Family Planning, EarlyView.
Abstract Conventional metrics of contraceptive need focus on contraceptive use among those not seeking pregnancy, ignoring individuals’ contraceptive preferences beyond pregnancy prevention. We examine contraceptive alignment, a novel metric describing agreement between actual and preferred method use/nonuse, among a 2022 nationally representative U.S.
Stephanie Arteaga, Ariana H. Bennett, Anu Manchikanti Gomez   +2 more
wiley   +1 more source

Evaluation of Serum IL-39 Levels in Patients with Polycystic Ovary Syndrome. [PDF]

J Clin Med
Kagitci M, Bahceci I, Kivrak M, Deseet SA, Senturk S.   +4 more
europepmc   +1 more source

Menopause and vascular endothelial health: Is it all about the oestrogen?

Experimental Physiology, EarlyView.
Abstract Cardiovascular disease (CVD) is a leading cause of mortality in women, and CVD risk is accelerated during the menopause transition. This acceleration has traditionally been attributed to the hallmark decline in oestradiol with menopause. However, the menopause transition is also characterized by changes in other sex hormones that exert effects
Virginia R. Nuckols, Allyson I. Schwab, Lyndsey E. DuBose, Kerrie L. Moreau, Megan M. Wenner   +4 more
wiley   +1 more source

Yoga as a complementary intervention for polycystic ovary Syndrome management: a systematic review. [PDF]

Front Reprod Health
Gautam R, Maan P, Arora A, Nair A, Ganie A, Chellamma J, Leelamma J, Jabbar PK, Arora T.   +8 more
europepmc   +1 more source

Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks

Experimental Physiology, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan, Stephanie Cowan, Chau Thien Tay, Lisa J. Moran, Ashley H. Ng   +4 more
wiley   +1 more source

Depressive and Anxiety Symptoms in Women with Polycystic Ovary Syndrome: A Meta-Analysis. [PDF]

J Clin Med
Stańczyk K, Łopacińska O, Kędzia D, Gawlik-Kotelnicka O.   +3 more
europepmc   +1 more source

Passive heat intervention research in women: Systematic review and audit of female representation

Experimental Physiology, EarlyView.
Abstract Passive heat interventions (PHIs) are non‐exercise heat‐acclimation strategies that improve physiological markers associated with heat tolerance and reduce vulnerability to heat‐related illness, when exercise is not feasible. However, representation of female participants within this literature remains unclear.
Jessica A. Mee, Olivia Barnes, Emma J. Lawrence, Gavin Thomas, Ben J. Duncan, Oliver R. Gibson, Ashley G. B. Willmott, Neil S. Maxwell   +7 more
wiley   +1 more source

Assessment of body composition, quality of life, and depression in women with polycystic ovary syndrome. [PDF]

Arch Endocrinol Metab
Ponce T, Vigário PDS, Almeida CP, Conceição FL.   +3 more
europepmc   +1 more source

Acute hot‐water immersion augments the diastolic blood pressure nocturnal dip in healthy adults

Experimental Physiology, EarlyView.
Abstract Hot‐water immersion (HWI) has been shown to reduce 24 h ambulatory systolic blood pressure in hypertensive adults and might represent a preventative strategy for maintaining cardiovascular health in normotensive adults. The purpose of this study was to determine the time course of post‐HWI hypotension and test the hypothesis that a single HWI ...
Samuel F. Leaney, Ferrida A. F. Ponce, Tomos F. Owen, Benjamin L. Harvey, Oliver N. Davies‐Wilson, Oliver M. A. Brand, Geoff B. Coombs, Jonathan P. Moore, Samuel J. Oliver   +8 more
wiley   +1 more source

Algae-Derived Bioactives Reprogram the Gut-SIRT1-Kisspeptin Axis in Polycystic Ovary Syndrome. [PDF]

Mar Drugs
Mustika A, Gorica E, Harbuwono DS, Kurniawati EM, Hadinata E, Hidayat AA, Siahaan SCPT, Hendarto H, Santini A, Nurkolis F.   +9 more
europepmc   +1 more source